A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-039

Clinical trial NCT03502954 · TERMINATED

Trial details

NCT number: NCT03502954
Sponsor: Affibody
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2018-02-26
Primary completion: 2020-02-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.